Lehrstuhl für Strahlentherapie

The IMMO-LDRT01 Study: Immunomodulatory Effects of X-ray Irradiation in chronic degenerative and inflammatory Diseases (2019) Donaubauer AJ, Gryc T, Froehlich B, Becker I, Ott OJ, Fietkau R, Gaipl U, Frey B Conference contribution Prognostic Importance of the CD8-based Immune Status Inflamed, immune-Excluded, and immune Desert in Head and Neck Cancer Patients can be further subdivided by regulatory T Cells (2019) Echarti A, Hecht M, Fietkau R, Distel L Conference contribution Complete Remission with consecutive Pneumonitis in metastatic Bronchogenic Carcinoma after combination of Radiotherapy and Nivolumab - Immunological Correlate in peripheral Blood (2019) Hecht M, Donaubauer AJ, Becker I, Rutzner S, Lubgan D, Lettmaier S, Haderlein M, et al. Conference contribution First Erlang Experience with Durvalumab Maintenance Therapy after definitive Radiochemotherapy in Patients with NSCLC (2019) Lettmaier S, Hecht M, Fietkau R Conference contribution Results of Re-Chemoradiotherapy in Patients with relapsed Glioblastoma WHO IV (2019) Mansoorian S, Lettmaier S, Goerig N, Weissmann T, Semrau S, Fietkau R, Putz F Conference contribution Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? (2019) Onbasi Y, Lettmaier S, Hecht M, Semrau S, Iro H, Kesting MR, Fietkau R, Haderlein M Journal article Impact of inter- and intra-observer variabilities of catheter reconstruction on multi-catheter interstitial brachytherapy of breast cancer patients (2019) Kallis K, Kaltsas T, Kreppner S, Lotter M, Strnad V, Fietkau R, Bert C Journal article Technical Note: A comparison of point set registration methods for electromagnetic tracking (2019) Götz TI, Wankerl H, Tomé AM, Meyer-Baese A, Bert C, Hensel B, Lang EW Journal article Salivary gland carcinoma (SGC) with perineural spread and/or positive resection margin - High locoregional control rates after photon (chemo) radiotherapy - Experience from a monocentric analysis (2019) Haderlein M, Scherl C, Semrau S, Lettmaier S, Hecht M, Putz F, Iro H, et al. Journal article PACIFIC-R: First real-world study of patients with unresectable, stage III NSCLC treated with durvalumab after chemoradiotherapy (2019) Girard N, Mornex F, Christoph DC, Fietkau R, Filippi AR, Field J, Garrido Lopez P, et al. Conference contribution